Proinflammatory IgG Fc structures in patients with severe COVID-19

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020) · Science · doi:10.1126/science.abb2507 · Cited by 8,897

Presumed Asymptomatic Carrier Transmission of COVID-19

Bai, Y., Yao, L., Wei, T., Tian, F., Jin, D., Chen, L., & Wang, M. (2020) · JAMA · doi:10.1001/jama.2020.2565 · Cited by 4,496

Epidemiology of COVID-19 Among Children in China

Dong, Y., Mo, X., Hu, Y., Qi, X., Jiang, F., Jiang, Z., & Tong, S. (2020) · PEDIATRICS · doi:10.1542/peds.2020-0702 · Cited by 4,240

Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study

Bi, Q., Wu, Y., Mei, S., Ye, C., Zou, X., Zhang, Z., Liu, X., Wei, L., Truelove, S., Zhang, T., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30287-5 · Cited by 1,960

A single-cell atlas of the peripheral immune response in patients with severe COVID-19

Wilk, A. J., Rustagi, A., Zhao, N. Q., Roque, J., Martínez-Colón, G. J., McKechnie, J. L., Ivison, G. T., Ranganath, T., Vergara, R., Hollis, T., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0944-y · Cited by 1,493

A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV

Yuan, M., Wu, N. C., Zhu, X., Lee, C.-C. D., So, R. T. Y., Lv, H., Mok, C. K. P., & Wilson, I. A. (2020) · Science · doi:10.1126/science.abb7269 · Cited by 1,429

Clinical Characteristics of 24 Asymptomatic Infections with COVID-19 Screened Among Close Contacts in Nanjing, China

Hu, Z., Song, C., Xu, C., Jin, G., Chen, Y., Xu, X., Ma, H., Chen, W., Lin, Y., Zheng, Y., et al. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1661-4 · Cited by 1,429

Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding

Xu, Y., Li, X., Zhu, B., Liang, H., Fang, C., Gong, Y., Guo, Q., Sun, X., Zhao, D., Shen, J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0817-4 · Cited by 1,415

Antibody-dependent enhancement of severe dengue disease in humans

Katzelnick, L. C., Gresh, L., Halloran, M. E., Mercado, J. C., Kuan, G. M., Gordon, A. L., Balmaseda, Á., & Harris, E. (2017) · Science · doi:10.1126/science.aan6836 · Cited by 1,202

Antibody glycosylation in COVID-19

Pongrácz, T., Vidarsson, G., & Wuhrer, M. (2022) · Glycoconjugate Journal · doi:10.1007/s10719-022-10044-0 · Cited by 27

Bulk IgG Glycosylation Predicts COVID-19 Severity and Vaccine Antibody Response

Ash, M. K., Bhimalli, P. P., Cho, B.-K., Mattamana, B. B., Gambut, S., Tarhoni, I., Fhied, C. L., Reyes, A. F., Welninski, S. J., Arivalagan, J., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111799 · Cited by 30

Fc‐ FcγR interactions during infections: From neutralizing antibodies to antibody‐dependent enhancement

Edgar, J. E., & Bournazos, S. (2024) · Immunological Reviews · doi:10.1111/imr.13393 · Cited by 32

Immunoglobulin G Immune Complexes May Contribute to Neutrophil Activation in the Course of Severe Coronavirus Disease 2019

Mazzitelli, I. G., Bleichmar, L., Ludueña, G., Pisarevsky, A. A., Labato, M. I., Chiaradia, V., Finocchietto, P. V., Paulín, F., Hormanstorfer, M., Baretto, M. C., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab174 · Cited by 26

Building a better antibody through the Fc: advances and challenges in harnessing antibody Fc effector functions for antiviral protection

Gunn, B. M., & Bai, S. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.1976580 · Cited by 28

Afucosylation of HLA-specific IgG1 as a potential predictor of antibody pathogenicity in kidney transplantation

Bharadwaj, P., Shrestha, S., Pongrácz, T., Catalano, C., Sharma, S., Moine, A. L., de Haan, N., Murakami, N., Riella, L. V., Holovská, V., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100818 · Cited by 26

Genetically diverse mouse models of SARS-CoV-2 infection reproduce clinical variation in type I interferon and cytokine responses in COVID-19

Robertson, S. J., Bedard, O., McNally, K. L., Shaia, C., Clancy, C. S., Lewis, M. C., Broeckel, R. M., Chiramel, A. I., Shannon, J. G., Sturdevant, G. L., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40076-5 · Cited by 28

IgG Glycosylation: Biomarker, Functional Modulator, and Structural Component

Radovani, B., & Nimmerjahn, F. (2024) · The Journal of Immunology · doi:10.4049/jimmunol.2400447 · Cited by 25

Optimized ACE2 decoys neutralize antibody-resistant SARS-CoV-2 variants through functional receptor mimicry and treat infection in vivo

Torchia, J. A., Tavares, A. H., Carstensen, L. S., Chen, D. W., Huang, J., Xiao, T., Mukherjee, S., Reeves, P. M., Tu, H., Sluder, A. E., et al. (2022) · Science Advances · doi:10.1126/sciadv.abq6527 · Cited by 25

Antibody and B Cell Responses to SARS-CoV-2 Infection and Vaccination: The End of the Beginning

Röltgen, K., & Boyd, S. D. (2023) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-031521-042754 · Cited by 25

Roles of core fucosylation modification in immune system and diseases

Pan, Q., & Zhang, X. (2024) · Cell Insight · doi:10.1016/j.cellin.2024.100211 · Cited by 24

Pediatric COVID-19: Immunopathogenesis, Transmission and Prevention

Rohner, G. B., Didierlaurent, A. M., Tilmanne, A., Smeesters, P. R., & Marchant, A. (2021) · Vaccines · doi:10.3390/vaccines9091002 · Cited by 28

Natural Killer Cell-Mediated Antibody-Dependent Cellular Cytotoxicity Against SARS-CoV-2 After Natural Infection Is More Potent Than After Vaccination

Rieke, G. J., van Bremen, K., Bischoff, J., ToVinh, M., Monin, M. B., Schlabe, S., Raabe, J., Kaiser, K. M., Finnemann, C., Odainic, A., et al. (2022) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac060 · Cited by 25

Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients

Sasson, J. M., Campo, J. J., Carpenter, R. M., Young, M. K., Randall, A. Z., Trappl, K., Oberai, A., Hung, C., Edgar, J. M., Teng, A., et al. (2021) · mBio · doi:10.1128/mbio.01229-21 · Cited by 26

Micro-Fourier-transform infrared reflectance spectroscopy as tool for probing IgG glycosylation in COVID-19 patients

Bandeira, C. C. S., Madureira, K. C. R., Rossi, M. B., Gallo, J. F., da Silva, A. P. M. A., Torres, V. L., de Lima, V. A., Kesper, N., Almeida, J. D., Zerbinati, R. M., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-08156-6 · Cited by 24

Neutralizing antibody activity against SARS-CoV-2 variants in gestational age–matched mother-infant dyads after infection or vaccination

Matsui, Y., Li, L., Prahl, M. K., Cassidy, A. G., Özarslan, N., Golan, Y., Gonzalez, V. J., Lin, C. Y., Jigmeddagva, U., Chidboy, M. A., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.157354 · Cited by 23

Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19

Gregory, D. J., Vannier, A., Duey, A. H., Roady, T. J., Dzeng, R. K., Pavlovic, M., Chapin, M. H., Mukherjee, S., Wilmot, H., Chronos, N., et al. (2022) · Virulence · doi:10.1080/21505594.2022.2073025 · Cited by 23

Heterogeneity in IgG‐CD16 signaling in infectious disease outcomes*

González, J. C., Chakraborty, S., Thulin, N. K., & Wang, T. T. (2022) · Immunological Reviews · doi:10.1111/imr.13109 · Cited by 24

Comparative analysis of spike-specific IgG Fc glycoprofiles elicited by adenoviral, mRNA, and protein-based SARS-CoV-2 vaccines

Coillie, J. V., Pongrácz, T., Šuštić, T., Wang, W., Nouta, J., Gars, M. L., Keijzer, S., Linty, F., Cristianawati, O., Keijser, J. B. D., et al. (2023) · iScience · doi:10.1016/j.isci.2023.107619 · Cited by 27

Immune age and biological age as determinants of vaccine responsiveness among elderly populations: the Human Immunomics Initiative research program

Goudsmit, J., van den Biggelaar, A. H. J., Koudstaal, W., Albert Hofman, D., Koff, W. C., Schenkelberg, T., Alter, G., Mina, M. J., & Wu, J. W. (2021) · European Journal of Epidemiology · doi:10.1007/s10654-021-00767-z · Cited by 22

Immune interventions in COVID-19: a matter of time?

Plaçais, L., Richier, Q., Noël, N., Lacombe, K., Mariette, X., & Hermine, O. (2021) · Mucosal Immunology · doi:10.1038/s41385-021-00464-w · Cited by 22

α2,6-Sialylation Is Upregulated in Severe COVID-19, Implicating the Complement Cascade

Qin, R., Kurz, E., Chen, S., Zeck, B., Chiribogas, L., Jackson, D., Herchen, A., Attia, T., Carlock, M. A., Rapkiewicz, A., et al. (2022) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.2c00421 · Cited by 21

Longitudinally monitored immune biomarkers predict the timing of COVID-19 outcomes

Lasso, G., Khan, S. M., Allen, S. A., Mariano, M. C., Florez, C., Orner, E. P., Quiroz, J. A., Quevedo, G., Massimi, A. B., Hegde, A., et al. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1009778 · Cited by 21

The Effect of Waning on Antibody Levels and Memory B Cell Recall following SARS-CoV-2 Infection or Vaccination

Forgacs, D., Silva‐Moraes, V., Sautto, G. A., Hanley, H. B., Gattiker, J. L., Jefferson, A. M., Kolhe, R. B., & Ross, T. M. (2022) · Vaccines · doi:10.3390/vaccines10050696 · Cited by 21

Immune complexes as culprits of immunopathology in severe COVID-19

Kolb, P., Giese, S., Voll, R. E., Hengel, H., & Falcone, V. (2022) · Medical Microbiology and Immunology · doi:10.1007/s00430-022-00743-8 · Cited by 21

Self-assembling peptide nanofiber HIV vaccine elicits robust vaccine-induced antibody functions and modulates Fc glycosylation

Chen, J., Fries, C. N., Berendam, S. J., Rodgers, N. S., Roe, E. F., Wu, Y., Li, S. H., Jain, R., Watts, B. E., Eudailey, J., et al. (2022) · Science Advances · doi:10.1126/sciadv.abq0273 · Cited by 21

The IgG glycome of SARS-CoV-2 infected individuals reflects disease course and severity

Siekman, S. L., Pongrácz, T., Wang, W., Nouta, J., Kremsner, P. G., Silva-Neto, P. V. D., Esen, M., Kreidenweiss, A., Held, J., Trapé, Á. A., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.993354 · Cited by 22

Composition of the immunoglobulin G glycome associates with the severity of COVID-19Preprint

Petrović, T., Alves, I., Bugada, D., Pascual, J., Vučković, F., Skelin, A., Gaifem, J., Villar-García, J., Vicente, M. M., Fernandes, Â., et al. (2020) · medRxiv · doi:10.1101/2020.10.17.20214205 · Cited by 20

COVID-19: Imbalanced Immune Responses and Potential Immunotherapies

Xie, B., Zhang, J., Li, Y., Yuan, S., & Shang, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.607583 · Cited by 19

Mechanism of glycoform specificity and in vivo protection by an anti-afucosylated IgG nanobody

Gupta, A., Kao, K. S., Yamin, R., Oren, D. A., Goldgur, Y., Du, J. J., Lollar, P., Sundberg, E. J., & Ravetch, J. V. (2023) · Nature Communications · doi:10.1038/s41467-023-38453-1 · Cited by 19

Non-neutralizing functions in anti-SARS-CoV-2 IgG antibodies

Reinig, S., & Shih, S. (2023) · Biomedical Journal · doi:10.1016/j.bj.2023.100666 · Cited by 22

The host glycomic response to pathogens

Qin, R., & Mahal, L. K. (2021) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2020.12.011 · Cited by 19

COVID-19 and HIV-Associated Immune Reconstitution Inflammatory Syndrome: Emergence of Pathogen-Specific Immune Responses Adding Fuel to the Fire

Seddiki, N., & French, M. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.649567 · Cited by 20

Coronavirus persistence in human respiratory tract and cell culture: An overview

Gaspar-Rodríguez, A., Padilla-González, A., & Rivera-Toledo, E. (2021) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2021.101632 · Cited by 19

Antibodies targeting conserved non-canonical antigens and endemic coronaviruses associate with favorable outcomes in severe COVID-19

Peddireddy, S. P., Rahman, S. A., Cillo, A. R., Vijay, G. K. M., Somasundaram, A., Workman, C. J., Bain, W., McVerry, B. J., Methé, B. A., Lee, J. S., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111020 · Cited by 19

Four keys to unlock IgG

Nimmerjahn, F., & Ravetch, J. V. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20201753 · Cited by 18

High-Throughput Profiling of Serological Immunoglobulin G N-Glycome as a Noninvasive Biomarker of Gastrointestinal Cancers

Liu, P., Wang, X., Dun, A., Li, Y., Li, H., Wang, L., Zhang, Y., Li, C., Zhang, J., Zhang, X., et al. (2023) · Engineering · doi:10.1016/j.eng.2023.02.008 · Cited by 18

A highly potent human neutralizing antibody prevents vertical transmission of Rift Valley fever virus in a rat model

McMillen, C. M., Chapman, N. S., Hoehl, R. M., Skvarca, L. B., Schwarz, M. M., Handal, L. S., Crowe, J. E., & Hartman, A. L. (2023) · Nature Communications · doi:10.1038/s41467-023-40187-z · Cited by 18

Robust and Functional Immune Memory Up to 9 Months After SARS-CoV-2 Infection: A Southeast Asian Longitudinal Cohort

Vo, H. T. M., Maestri, A., Auerswald, H., Sorn, S., Lay, S., Seng, H., Sann, S., Ya, N., Pean, P., Dussart, P., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.817905 · Cited by 19

New-Onset and Relapsed Membranous Nephropathy post SARS-CoV-2 and COVID-19 Vaccination

Ma, Q., Li, X., & Xu, G. (2022) · Viruses · doi:10.3390/v14102143 · Cited by 18

Decay of Fc-dependent antibody functions after mild to moderate COVID-19

Lee, W. S., Selva, K. J., Davis, S. K., Wines, B. D., Reynaldi, A., Esterbauer, R., Kelly, H. G., Haycroft, E. R., Tan, H.-X., Juno, J. A., et al. (2020) · doi:10.1101/2020.12.13.20248143 · Cited by 80

COVID-19 and earlier pandemics, sepsis, and vaccines: A historical perspective

Cavaillon, J.-M., & Osuchowski, M. F. (2021) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2021.04.003 · Cited by 17

Structure, function, and implications of fucosyltransferases in health and disease

Ghirardello, M., Yruela, I., Merino, P., Sackstein, R., Sanz‐Martínez, I., & Hurtado‐Guerrero, R. (2025) · Nature Communications · doi:10.1038/s41467-025-66871-w · Cited by 17

Synthetic nanobodies as tools to distinguish IgG Fc glycoforms

Kao, K. S., Gupta, A., Zong, G., Li, C., Kerschbaumer, I., Borghi, S., Achkar, J. M., Bournazos, S., Wang, L., & Ravetch, J. V. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2212658119 · Cited by 17

Human Plasma IgG N -Glycome Profiles Reveal a Proinflammatory Phenotype in Chronic Thromboembolic Pulmonary Hypertension

Zhang, Z., Wang, H., Lian, T., Zhou, Y., Xu, X., Guo, F., Wei, Y., Li, J., Sun, K., Liu, C., et al. (2023) · Hypertension · doi:10.1161/hypertensionaha.123.21408 · Cited by 17

A highly specific antibody against the core fucose of the N-glycan in IgG identifies the pulmonary diseases and its regulation by CCL2

Kanto, N., Ohkawa, Y., Kitano, M., Maeda, K., Shiida, M., Ono, T., Ota, F., Kizuka, Y., Kunimasa, K., Nishino, K., et al. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105365 · Cited by 17

Persistent but dysfunctional mucosal SARS-CoV-2-specific IgA and low lung IL-1β associate with COVID-19 fatal outcome: A cross-sectional analysis

Ruiz, M. J., Siracusano, G., Cottignies-Calamarte, A., Tudor, D., Real, F., Zhu, A., Pastori, C., Capron, C., Rosenberg, A. R., Temperton, N. J., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.842468 · Cited by 21

Optimization of Anti-SARS-CoV-2 Neutralizing Antibody Therapies: Roadmap to Improve Clinical Effectiveness and Implementation

van der Straten, K., van Gils, M. J., de Taeye, S. W., & de Bree, G. J. (2022) · Frontiers in Medical Technology · doi:10.3389/fmedt.2022.867982 · Cited by 17

D-dimer and CoV-2 spike-immune complexes contribute to the production of PGE2 and proinflammatory cytokines in monocytes

Park, Y.-J., Acosta, D. I., Vassell, R. A., Tang, J., Khurana, S., Weiss, C. D., Golding, H., & Zaitseva, M. B. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010468 · Cited by 16

Evaluation of Antibody-Dependent Fc-Mediated Viral Entry, as Compared With Neutralization, in SARS-CoV-2 Infection

Wieczorek, L., Zemil, M., Merbah, M., Dussupt, V., Kavusak, E., Molnar, S., Heller, J., Beckman, B., Wollen-Roberts, S. E., Peachman, K. K., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.901217 · Cited by 16

Harnessing IgG Fc glycosylation for clinical benefit

Archer, E. J., González, J. C., Ghosh, D., Mellins, E., & Wang, T. T. (2022) · Current Opinion in Immunology · doi:10.1016/j.coi.2022.102231 · Cited by 15

Polyfunctional antibodies: a path towards precision vaccines for vulnerable populations

Purcell, R. A., Theisen, R. M., Arnold, K. B., Chung, A. W., & Selva, K. J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1183727 · Cited by 16

Antibody‐mediated control mechanisms of viral infections

Mackin, S., Sariol, A., & Diamond, M. (2024) · Immunological Reviews · doi:10.1111/imr.13383 · Cited by 15

Systems Glycobiology: Immunoglobulin G Glycans as Biomarkers and Functional Effectors in Aging and Diseases

Kavur, M. M., Lauc, G., & Pezer, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819475-1.00086-9 · Cited by 15

The Importance of Glycosylation in COVID-19 Infection

Pribić, T., Lauc, G., & Trbojević‐Akmačić, I. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-70115-4_12 · Cited by 15

Omicron variants breakthrough infection elicited higher specific memory immunity than third dose booster in healthy vaccinees

Yu, P., Liu, Z., Zhu, Z., Yang, J., Deng, M., Chen, M., Lai, C., Kong, W., Xiong, S., Wan, L., et al. (2023) · Virologica Sinica · doi:10.1016/j.virs.2022.12.008 · Cited by 14

Immunology of SARS-CoV-2 infections and vaccines

Schenten, D., & Bhattacharya, D. (2021) · Advances in immunology · doi:10.1016/bs.ai.2021.08.002 · Cited by 14

Defining Clinical and Immunological Predictors of Poor Immune Responses to COVID-19 mRNA Vaccines in Patients with Primary Antibody Deficiency

Shin, J. J., Par‐Young, J., Ünlü, S., McNamara, A., Park, H., Shin, M. S., Gee, R. J., Doyle, H. A., Afinogenova, Y., Zidan, E., et al. (2022) · Journal of Clinical Immunology · doi:10.1007/s10875-022-01296-4 · Cited by 14

Glyco engineered pentameric SARS-CoV-2 IgMs show superior activities compared to IgG1 orthologues

Kallolimath, S., Palt, R., Föderl-Höbenreich, E., Sun, L., Chen, Q., Pruckner, F., Eidenberger, L., Strasser, R., Zatloukal, K., & Steinkellner, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1147960 · Cited by 14

Diverging Maternal and Cord Antibody Functions From SARS-CoV-2 Infection and Vaccination in Pregnancy

Adhikari, E. H., Lu, P., Kang, Y. J., McDonald, A. R., Pruszynski, J. E., Bates, T. A., McBride, S. K., Trank-Greene, M., Tafesse, F., & Lu, L. L. (2023) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiad421 · Cited by 15

Antibodies as key mediators of protection against Mycobacterium tuberculosis

Wang, Q., Nag, D., Baldwin, S. L., Coler, R. N., & McNamara, R. P. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1430955 · Cited by 13

Advances in understanding the formation and fate of B-cell memory in response to immunization or infection

Kealy, L. C., & Good‐Jacobson, K. L. (2021) · Oxford Open Immunology · doi:10.1093/oxfimm/iqab018 · Cited by 14

Mitochondrial regulation of acute extrafollicular B‐cell responses to COVID‐19 severity

Cao, T., Liu, L., To, K. K., Lim, C., Zhou, R., Ming, Y., Kwan, K., Yu, S., Chan, C., Zhou, B., et al. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.1025 · Cited by 13

The Role of Immunity in the Pathogenesis of SARS-CoV-2 Infection and in the Protection Generated by COVID-19 Vaccines in Different Age Groups

Abdulla, Z. A., Al-Bashir, S. M., Alzoubi, H., Al-Salih, N. S., Aldamen, A. A., & Abdulazeez, A. Z. (2023) · Pathogens · doi:10.3390/pathogens12020329 · Cited by 13

Borrelia-specific antibody profiles and complement deposition in joint fluid distinguish antibiotic-refractory from -responsive Lyme arthritis

Bowman, K. A., Wiggins, C. D., DeRiso, E. A., Paul, S. B., Strle, K., Branda, J. A., Steere, A. C., Lauffenburger, D. A., & Alter, G. (2024) · iScience · doi:10.1016/j.isci.2024.108804 · Cited by 12

Spectrochemical and explainable artificial intelligence approaches for molecular level identification of the status of critically ill patients with COVID-19

Tokgoz, G., Kırboğa, K. K., Özel, F., Yücepur, S., Ardahanlı, İ., & Gurbanov, R. (2024) · Talanta · doi:10.1016/j.talanta.2024.126652 · Cited by 12

Neutrophil Heterogeneity in Airway Inflammatory Diseases

Guo, D.-Y., Liu, Z., Xu, X.-C., Yu, J.-K., Zhou, J.-S., Li, Z., Lv, B., Xu, T., & Chen, Z. (2025) · Inflammation · doi:10.1007/s10753-025-02351-z · Cited by 13

Modalities and Mechanisms of Treatment for Coronavirus Disease 2019

Zuo, Z., Wu, T., Pan, L., Zuo, C., Hu, Y., Luo, X., Jiang, L., Xia, Z., Xiao, X., Liu, J., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.583914 · Cited by 14

COVID-19: Structural Considerations for Virus Pathogenesis, Therapeutic Strategies and Vaccine Design in the Novel SARS-CoV-2 Variants Era

Volkan, E. (2021) · Molecular Biotechnology · doi:10.1007/s12033-021-00353-4 · Cited by 12

Determination of IgG1 and IgG3 SARS-CoV-2 Spike Protein and Nucleocapsid Binding—Who Is Binding Who and Why?

Iles, J. K., Zmuidinaite, R., Sadée, C., Gardiner, A. E., Lacey, J., Harding, S. J., Wallis, G. L. F., Patel, R., Roblett, D., Heeney, J. L., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116050 · Cited by 12

IgG targeting distinct seasonal coronavirus- conserved SARS-CoV-2 spike subdomains correlates with differential COVID-19 disease outcomes

Garrido, J. L. V., Medina, M. A., Bravo, F., McGee, S., Fuentes‐Villalobos, F., Calvo, M. A., Pinos, Y., Bowman, J. W., Bahl, C. D., Barría, M. I., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110904 · Cited by 13

Navigating the Covid-19 Pandemic by Caring for Our Health Care Workforce as They Care for Our Patients

Frush, K. S., Lee, G. M., Wald, S. H., Hawn, M. T., Krna, C. D., Holubar, M. K., Beatty, D. E., Chawla, A., Pinsky, B. A., Schilling, L. M., et al. (2020) · NEJM Catalyst · doi:10.1056/cat.20.0378 · Cited by 11

Severe Clinical Worsening in COVID-19 and Potential Mechanisms of Immune-Enhanced Disease

Hussman, J. P. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.637642 · Cited by 11

Efficient Maternal to Neonate Transfer of Neutralizing Antibodies after SARS-CoV-2 Vaccination with BNT162b2: A Case-Report and Discussion of the Literature

Douxfils, J., Gillot, C., Gottal, É. D., Vandervinne, S., Bayart, J., Dogné, J., & Favresse, J. (2021) · Vaccines · doi:10.3390/vaccines9080907 · Cited by 11

Importance and Monitoring of Therapeutic Immunoglobulin G Glycosylation

Mimura, Y., Saldova, R., Mimura‐Kimura, Y., Rudd, P. M., & Jefferis, R. (2021) · Experientia supplementum · doi:10.1007/978-3-030-76912-3_15 · Cited by 11

Differential Peripheral Blood Glycoprotein Profiles in Symptomatic and Asymptomatic COVID-19

Pickering, C., Zhou, B., Xu, G., Rice, R. A., Ramachandran, P., Huang, H. H., Pham, T. D., Schapiro, J. M., Xin, C., Chakraborty, S., et al. (2022) · Viruses · doi:10.3390/v14030553 · Cited by 11

Circulating multimeric immune complexes drive immunopathology in COVID-19Preprint

Ankerhold, J., Giese, S., Kolb, P., Maul-Pavicic, A., Voll, R. E., Göppert, N., Ciminski, K., Kreutz, C., Lother, A., Salzer, U., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.25.449893 · Cited by 13

Infection and the Glycome─New Insights into Host Response

Mohideen, F. I., & Mahal, L. K. (2024) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.4c00315 · Cited by 11

Biophysical Evaluation of Rhesus Macaque Fc Gamma Receptors Reveals Similar IgG Fc Glycoform Preferences to Human Receptors

Crowley, A. R., Osei‐Owusu, N. Y., Dekkers, G., Gao, W., Wuhrer, M., Magnani, D. M., Reimann, K. A., Pincus, S. H., Vidarsson, G., & Ackerman, M. E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.754710 · Cited by 11

A functional spleen contributes to afucosylated IgG in humans

Wójcik, I., Schmidt, D. E., de Neef, L. A., Rab, M. A. E., Meek, B., de Weerdt, O., Wuhrer, M., van der Schoot, C. E., Zwaginga, J. J., de Haas, M., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-03196-w · Cited by 10

Identification of new drugs to counteract anti-spike IgG-induced hyperinflammation in severe COVID-19

Geyer, C. E., Chen, H., Bye, A. P., Manz, X. D., Guerra, D., Caniels, T. G., Bijl, T. P. L., Griffith, G. R., Hoepel, W., de Taeye, S. W., et al. (2023) · Life Science Alliance · doi:10.26508/lsa.202302106 · Cited by 10

Serum immunoglobulin and the threshold of Fc receptor-mediated immune activation

Bauer-Smith, H., Sudol, A. S. L., Beers, S. A., & Crispin, M. (2023) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2023.130448 · Cited by 10

Anti-MDA5 antibody IgG1 subtype is associated with rapidly progressive interstitial lung disease in anti-MDA5-positive dermatomyositis

Wu, Y., Wang, Y., Qiu, Y., Lv, C., Zhu, Y., Wang, L., Xu, L., You, H., Wang, F., & Tan, W. (2025) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-025-03921-y · Cited by 9

Antibody glycosylation directs innate and adaptive immune collaboration

Polmear, J., & Good‐Jacobson, K. L. (2021) · Current Opinion in Immunology · doi:10.1016/j.coi.2021.12.002 · Cited by 9

Does SARS-CoV-2 Induce IgG4 Synthesis to Evade the Immune System?

Rubio‐Casillas, A., Redwan, E. M. M. M., & Uversky, V. N. (2023) · Biomolecules · doi:10.3390/biom13091338 · Cited by 9

A predictive model for disease severity among COVID-19 elderly patients based on IgG subtypes and machine learning

Zhuang, Z., Qi, Y., Yao, Y., & Yu, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1286380 · Cited by 9

COVID-19 IgG/IgM patterns, early IL-6 elevation and long-term radiological sequelae in 75 patients hospitalized due to interstitial pneumonia followed up from 3 to 12 months

Toraldo, D. M., Satriano, F., Rollo, R., Verdastro, G., Imbriani, G., Rizzo, E., Argentiero, A., Falco, A., Ambrosino, P., Miani, A., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262911 · Cited by 9

Afucosylation of anti-dengue IgG is associated with enhanced susceptibility to dengue virus infection postvaccination

Ashraf, U., Chakraborty, S., Scallan, C., Lo, N. C., Alera, M. T., Farmer, A. R., Chua, M. N., Michael, N. L., Rothman, A. L., & Wang, T. T. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adx7231 · Cited by 8

Activation of Intracellular Complement in Lungs of Patients With Severe COVID-19 Disease Decreases T-Cell Activity in the Lungs

Howell, M., Green, R. J., McGill, A. R., Kahlil, R. M., Dutta, R., Mohapatra, S. S., & Mohapatra, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.700705 · Cited by 8

Noninvasive nasopharyngeal proteomics of COVID-19 patient identify abnormalities related to complement and coagulation cascade and mucosal immune system

Ayass, M. A., Cao, W., Zhang, J., Dai, J., Zhu, K., Tripathi, T., Griko, N., Pashkov, V., & Abi-Mosleh, L. (2022) · PLoS ONE · doi:10.1371/journal.pone.0274228 · Cited by 8

Impact of SARS-CoV-2 vaccination on FcγRIIIA/CD16 dynamics in Natural Killer cells: relevance for antibody-dependent functions

Capuano, C., Federicis, D. D., Ciuti, D., Turriziani, O., Angeloni, A., Anastasi, E., Giannini, G., Belardinilli, F., Molfetta, R., Alvaro, D., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1285203 · Cited by 8

Integrated bioinformatics to identify potential key biomarkers for COVID-19-related chronic urticaria

Zhang, T., Feng, H., Zou, X., & Peng, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1054445 · Cited by 8

Dynamics of Different Classes and Subclasses of Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Variants after Coronavirus Disease 2019 and CoronaVac Vaccination in Thailand

Poolchanuan, P., Matsee, W., Sengyee, S., Siripoon, T., Dulsuk, A., Phunpang, R., Pisutsan, P., Piyaphanee, W., Luvira, V., & Chantratita, N. (2023) · mSphere · doi:10.1128/msphere.00465-22 · Cited by 8

The Functional Roles of MDSCs in Severe COVID-19 Pathogenesis

Chan, K. R., Len, J. S., & Koh, C. W. (2023) · Viruses · doi:10.3390/v16010027 · Cited by 8

Total plasma N-glycomic signature of SARS-CoV-2 infection

Bladergroen, M. R., Pongrácz, T., Wang, W., Nicolardi, S., Arbous, M. S., Roukens, A. H. E., & Wuhrer, M. (2024) · iScience · doi:10.1016/j.isci.2024.110374 · Cited by 7

Identification of nafamostat mesylate as a selective stimulator of NK cell IFN-γ production via metabolism-related compound library screening

Yang, Q., Zhang, S., Wu, S., Yao, B., Wang, L., Li, Y., Peng, H., Huang, M., Bi, Q., Xiong, P., et al. (2022) · Immunologic Research · doi:10.1007/s12026-022-09266-z · Cited by 7

Coronavirus Disease 2019-Related Alterations of Total and Anti-Spike IgG Glycosylation in Relation to Age and Anti-Spike IgG Titer

Schwedler, C., Grzeski, M., Kappert, K., Rust, J., Heymann, G. A., Hoppe, B., & Blanchard, V. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.775186 · Cited by 8

IGHG3 hinge length variation was associated with the risk of critical disease and death in a Spanish COVID-19 cohort

López‐Martínez, R., Albaiceta, G. M., Amado‐Rodríguez, L., Gómez, J., Cuesta‐Llavona, E., Clemente, M. M. G., Hermida-Valverde, T., Enríquez-Rodríguez, A. I., Hernández-González, C., Martı́nez-Borra, J., et al. (2022) · Genes and Immunity · doi:10.1038/s41435-022-00179-3 · Cited by 7

Increased von Willebrand Factor Platelet-Binding Capacity Is Related to Poor Prognosis in COVID-19 Patients

Stefanini, L., Ruberto, F., Curreli, M., Chistolini, A., Schiera, E., Marrapodi, R., Visentini, M., Ceccarelli, G., d’Ettorre, G., Santoro, C., et al. (2022) · Thrombosis and Haemostasis · doi:10.1055/a-1962-5447 · Cited by 7

Antibodies to the RBD of SARS-CoV-2 spike mediate productive infection of primary human macrophages

Pickering, S., Wilson, H., Bravo, E., Perera, M. R., Seow, J., Graham, C., Almeida, N., Fotopoulos, L., Williams, T., Moitra, A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54458-w · Cited by 6

Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity

Chakraborty, S., González, J. C., Sievers, B. L., Mallajosyula, V. V. A., Chakraborty, S., Dubey, M., Ashraf, U., Cheng, B. Y.-L., Kathale, N. D., Tran, K. Q. T., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abm7853 · Cited by 137

Immunoglobulin G1 Fc glycosylation as an early hallmark of severe COVID-19

Pongrácz, T., Nouta, J., Wang, W., van Meijgaarden, K. E., Linty, F., Vidarsson, G., Joosten, S. A., Ottenhoff, T. H. M., Hokke, C. H., de Vries, J. J. C., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103957 · Cited by 68

Altered Spike Immunoglobulin G Fc N-Linked Glycans Are Associated With Hyperinflammatory State in Adult Coronavirus Disease 2019 and Multisystem Inflammatory Syndrome in Children

Sherman, J. D., Karmali, V., Kumar, B., Simon, T. W., Bechnak, S., Panjwani, A., Ciric, C. R., Wang, D., Huerta, C., Johnson, B. E., et al. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae626 · Cited by 1

Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity

Larsen, M. D., de Graaf, E. L., Sonneveld, M. E., Plomp, H. R., Nouta, J., Hoepel, W., Chen, H.-J., Linty, F., Visser, R., Brinkhaus, M., et al. (2021) · Science · doi:10.1126/science.abc8378 · Cited by 408

Altered spike IgG Fc N-linked glycans are associated with hyperinflammatory state in adult COVID and Multisystem Inflammatory Syndrome in ChildrenPreprint

Sherman, J. D., Karmali, V., Kumar, B., Simon, T. W., Bechnak, S., Panjwani, A., Ciric, C. R., Wang, D., Huerta, C., Johnson, B. E., et al. (2024) · medRxiv · doi:10.1101/2024.07.14.24310381